feed,title,long_url,short_url
Benzinga,Argenx's Flagship Neuromuscular Treatment For Subcutaneous Injection Goes Under Priority FDA Review,https://benzinga.com/general/biotech/22/11/29817639/argenxs-flagship-neuromuscular-treatment-for-subcutaneous-injection-goes-under-priority-fda-revie,https://bit.ly/3Xq4iCQ
Benzinga,Novavax Terminates Agreement With GAVI Alliance For Sale Of Its COVID-19 Vaccines,https://benzinga.com/general/biotech/22/11/29817467/novavax-terminates-agreement-with-gavi-alliance-for-sale-of-its-covid-19-vaccines,https://bit.ly/3Xq4j9S
